Anti-thymocyte globulin and prednisone immunotherapy of recent onset type 1 diabetes mellitus

Diabetes Research

Volumn 2, Issue 6, 1985, Pages 271-276

  Eisenbarth, G S ^a   Srikanta, S ^a   Jackson, R ^a   Rabinowe, S ^b   Dolinar, R ^b   Aoki, T ^b   Morris, M A ^b  

^a JOSLIN DIABETES CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; DIPHENHYDRAMINE; GLUCAGON; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; PARACETAMOL; PLACEBO; PREDNISONE; THYMOCYTE ANTIBODY;

ADVERSE DRUG REACTION; AUTOIMMUNITY; BLOOD AND HEMOPOIETIC SYSTEM; BRONCHOSPASM; CLINICAL ARTICLE; CUSHINGOID SYNDROME; DRUG THERAPY; ENDOCRINE SYSTEM; FEVER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG TOXICITY; PRIORITY JOURNAL; RASH; RESPIRATORY SYSTEM; SKIN TOXICITY; T LYMPHOCYTE; THERAPY; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; ANTILYMPHOCYTE SERUM; C-PEPTIDE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPOGLYCEMIA; IMMUNOTHERAPY; MALE; PREDNISONE; T-LYMPHOCYTES; THROMBOCYTOPENIA; TIME FACTORS;

EID: 0022348847     PISSN: 02655985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)